Crossmark

Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study

Crossref DOI link: https://doi.org/10.1136/rmdopen-2024-004382

Published Online: 2024-06-21

Published Print: 2024-06

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

van der Pol, Joy Ardjuna https://orcid.org/0000-0003-0721-9913
Allaart, Cornelia F

Huizinga, Tom W J https://orcid.org/0000-0001-7033-7520
Bergstra, Sytske Anne https://orcid.org/0000-0002-7136-5248
Funding

Funding for this research was provided by:

AbbVie (NA)
License Information

License valid from 2024-06-21